Delayed
Japan Exchange
11:26:43 16/05/2024 am IST
|
5-day change
|
1st Jan Change
|
156
JPY
|
-4.29%
|
|
-2.50%
|
-36.84%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
25,399
|
10,421
|
Enterprise Value (EV)
1 |
19,117
|
3,904
|
P/E ratio
|
21.6
x
|
-5.02
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
2.54
x
|
1.86
x
|
EV / Revenue
|
1.91
x
|
0.7
x
|
EV / EBITDA
|
9.27
x
|
-5.47
x
|
EV / FCF
|
12.4
x
|
-27.2
x
|
FCF Yield
|
8.07%
|
-3.68%
|
Price to Book
|
2.99
x
|
1.45
x
|
Nbr of stocks (in thousands)
|
39,501
|
42,191
|
Reference price
2 |
643.0
|
247.0
|
Announcement Date
|
23/03/23
|
22/03/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net sales
1 |
10,008
|
5,589
|
EBITDA
1 |
2,063
|
-714
|
EBIT
1 |
1,964
|
-812
|
Operating Margin
|
19.62%
|
-14.53%
|
Earnings before Tax (EBT)
1 |
2,106
|
-1,195
|
Net income
1 |
1,179
|
-1,962
|
Net margin
|
11.78%
|
-35.1%
|
EPS
2 |
29.77
|
-49.17
|
Free Cash Flow
1 |
1,542
|
-143.5
|
FCF margin
|
15.41%
|
-2.57%
|
FCF Conversion (EBITDA)
|
74.75%
|
-
|
FCF Conversion (Net income)
|
130.8%
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
23/03/23
|
22/03/24
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
---|
Net sales
1 |
1,360
|
3,146
|
EBITDA
|
-
|
-
|
EBIT
1 |
-1,839
|
-194
|
Operating Margin
|
-135.22%
|
-6.17%
|
Earnings before Tax (EBT)
1 |
-1,883
|
-203
|
Net income
1 |
-1,884
|
-205
|
Net margin
|
-138.53%
|
-6.52%
|
EPS
2 |
-62.47
|
-5.370
|
Dividend per Share
2 |
-
|
-
|
Announcement Date
|
05/08/20
|
04/08/21
|
Fiscal Period: December |
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
Net Cash position
1 |
6,282
|
6,517
|
Leverage (Debt/EBITDA)
|
-
|
-
|
Free Cash Flow
1 |
1,542
|
-144
|
ROE (net income / shareholders' equity)
|
15.5%
|
-25%
|
ROA (Net income/ Total Assets)
|
13%
|
-5.46%
|
Assets
1 |
9,070
|
35,960
|
Book Value Per Share
2 |
215.0
|
171.0
|
Cash Flow per Share
2 |
159.0
|
154.0
|
Capex
1 |
2
|
204
|
Capex / Sales
|
0.02%
|
3.65%
|
Announcement Date
|
23/03/23
|
22/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -36.84% | 48.22M | | +31.37% | 595B | | -2.60% | 367B | | +20.83% | 334B | | +5.69% | 289B | | +14.83% | 239B | | +9.93% | 211B | | -6.95% | 203B | | +10.77% | 171B | | +0.10% | 163B |
Other Pharmaceuticals
|